Form 4: INTEST CORP: Rogoff Reports Stock Transactions
Statement of Changes in Beneficial Ownership
Richard B. Rogoff, President and CEO of INTEST CORP, reported transactions involving stock options and restricted stock units.
Summary
- Richard B. Rogoff, President and CEO and Director of INTEST CORP, has filed a Form 4 detailing changes in his beneficial ownership of company securities.
- The filing includes information on stock options and restricted stock units, with various vesting schedules and exercise prices.
- Specifically, a stock option grant on March 31, 2026, for 300,000 shares with an exercise price of $13.65, is noted, with vesting contingent on achieving certain volume-weighted average prices.
- Restricted stock units (RSUs) that convert to common stock on a one-for-one basis are also detailed, with vesting scheduled over several years.
- Several other stock options with different exercise prices and vesting commencement dates are listed, indicating ongoing equity-based compensation and incentives.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing. It reports routine insider transactions without providing new financial performance data or strategic insights that would significantly alter investment sentiment.
Positives
- The filing indicates continued equity incentives for key management, aligning their interests with shareholders.
- The structure of some option grants, tied to volume-weighted average prices, suggests a performance-based component to compensation.
- The reporting of these transactions demonstrates transparency and compliance with SEC regulations.
Negatives
- The filing does not provide specific financial performance data or context for these equity grants.
- The vesting conditions for the large stock option grant are performance-dependent, meaning the actual benefit to the executive is not guaranteed.
Risks
- The vesting of a significant stock option grant (300,000 shares) is contingent on the company's stock price performance, indicating a risk that these options may not vest if market conditions are unfavorable.
- The overall compensation structure, heavily reliant on stock options and RSUs, exposes management's financial benefit to market volatility.
Future Outlook
The future outlook is not directly addressed in this Form 4 filing, which primarily reports on past transactions and current beneficial ownership. However, the vesting conditions for certain stock options are tied to future stock price performance, implying a positive outlook is anticipated for these to be realized.
Management Comments
- The filing is a standard SEC Form 4 and does not contain direct quotes or commentary from management.
- The signature block indicates that Duncan Gilmour acted as an Attorney-in-Fact for Richard B. Rogoff.
Industry Context
StockSavvy.ai notes that Form 4 filings are routine disclosures for corporate insiders, providing transparency into their stock transactions. The details of stock options and RSUs are common in the technology and manufacturing sectors, where INTEST CORP operates, as a means to attract, retain, and incentivize executive talent.
Stakeholder Impact
- Shareholders: The filing provides transparency into insider holdings and potential future dilution from option exercises. The performance-based vesting of some options aligns management's interests with shareholder value creation.
- Employees: The existence of stock incentive plans, as evidenced by these grants, suggests a broader employee equity program that can motivate and retain staff.
- Management: The filing details the equity compensation awarded to Richard B. Rogoff, impacting his personal financial stake in the company.
Next Steps
- The vesting of stock options and restricted stock units will occur according to the schedules and conditions outlined in the filing.
- Future transactions by Richard B. Rogoff will be reported on subsequent Form 4 filings.
Key Dates
| Date | Description |
|---|---|
| 03/05/2034 | Vesting commencement date for a stock option. |
| 03/07/2033 | Vesting commencement date for a stock option. |
| 03/15/2036 | Expiration date for a stock option. |
| 03/16/2027 | Vesting commencement date for a stock option. |
| 03/17/2027 | Vesting installment date for restricted stock units. |
| 03/17/2028 | Vesting installment date for restricted stock units. |
| 03/17/2029 | Vesting installment date for restricted stock units. |
| 03/31/2026 | Transaction date for a stock option grant and earliest transaction date reported. |
| 03/31/2036 | Expiration date for a stock option. |
| 04/02/2026 | Date of signature for the filing. |
| 04/27/2032 | Vesting commencement date for a stock option. |
| 03/17/2025 | Vesting commencement date for a stock option. |
| 03/17/2026 | Vesting commencement date for a stock option. |
| 04/28/2023 | Vesting commencement date for a stock option. |
Keywords
Form 4, SEC Filing, INTEST CORP, INTT, Richard B. Rogoff, Stock Options, Restricted Stock Units, Beneficial Ownership, Insider Trading, Equity Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.